Related Experiment Video
Updated: Apr 8, 2026
08:34
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
21.3K
External beam radiotherapy for localized prostate cancer.
Hasan Yilmaz, Gorkem Aksu, Ozdal Dillioglugil1
1Kocaeli University, School of Medicine, Department of Urology, Kocaeli, Turkey.
Asian Journal of Andrology
|June 27, 2015
Summary
External beam radiation therapy (XRT) offers a curative option for prostate cancer (PCa). Advanced XRT techniques combined with hormonotherapy (HT) enhance treatment efficacy and minimize side effects for localized PCa.
Area of Science:
- Oncology
- Radiation Oncology
Background:
- Prostate cancer (PCa) is a significant health concern.
- Radiotherapy (XRT) is a primary curative treatment modality for PCa.
- Advancements in XRT technology enable dose escalation with improved precision.
Purpose of the Study:
- To review current literature and guidelines for external beam radiation therapy (XRT) in prostate cancer (PCa) management.
- To highlight the benefits of combining XRT with hormonotherapy (HT).
Main Methods:
- Comprehensive literature search of peer-reviewed articles and clinical guidelines.
- Focus on external beam radiation therapy techniques for localized PCa.
- Exclusion of brachytherapy and radiosurgery from the review scope.
Main Results:
- Modern XRT allows for higher radiation doses, improving local control.
- XRT leads to reduced damage to surrounding tissues.
- Neoadjuvant or adjuvant hormonotherapy (HT) significantly enhances the curative effects of XRT.
Conclusions:
- External beam radiation therapy is a cornerstone of curative treatment for prostate cancer.
- Technological advancements in XRT are enhancing treatment outcomes.
- The integration of hormonotherapy with XRT represents an effective strategy for improving prostate cancer cure rates.
